Lilly Company (India) Pvt Ltd has announced the launch
of Humalog Mix, a variant of its existing anti-diabetes
insulin analog mixture, Humalog, at a press conference
As compared to other anti-diabetes drugs that need to
be administered before meals at a stipulated time, the
new drug can be administered immediately before or after
meals, thus offering convenience, control and flexibility
to the patient. The company claims that the drug is also
less painful than the normal insulin injections available
at the press conference, Rajiv Gulati, chairman and managing
director of Eli Lilly India, said, " Humalog Mix
has been designed specifically for the Indian individual,
keeping in mind the irregular food and lifestyle habits
prevalent here. Also, Humalog Mix offers more effective
diabetes control without being as painful as the other
Mix is a prescription drug available in three variations:
Humalog Mix 25, Humalog Mix 50 and Humalog insulin lispro.
The drug is priced at Rs396 per cartridge.
Lilly's Humalog was launched in 1997 in India. According
to company statistics, over one lakh patients in India
are currently using Humalog.
company also claims that Humalog Mix 50 is currently available
only in Japan and India.
Lilly had reported a turn over for Rs150 crore for the
previous financial year.